Form 483

GAMBRO ROSTOCK GMBH Form 483, 2017-07-06

FDA issued a Form 483 to GAMBRO ROSTOCK GMBH on 2017-07-06 with 8 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health8 observations

GAMBRO ROSTOCK GMBH · Rostock, Germany · Issued July 6, 2017

Overview

  • 8 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

6 Jul 2017
21 CFR 803.56

Submission Within One Month

Cited by Donna L Besone

6 Jul 2017
21 CFR 803.56

Submission Within One Month

Cited by Donna L Besone

6 Jul 2017
21 CFR 820.250(a)

Statistical techniques - Lack of or inadequate procedures

Cited by Donna L Besone

6 Jul 2017
21 CFR 820.250(a)

Statistical techniques - Lack of or inadequate procedures

Cited by Donna L Besone

6 Jul 2017
21 CFR 820.30(g)

Design validation - Risk analysis

Cited by Donna L Besone

Inspected site

GRGAMBRO ROSTOCK GMBHRostock, Germany

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 803.56Cited across public-safe Form 483 observations2x
21 CFR 820.250(a)Cited across public-safe Form 483 observations2x
21 CFR 820.30(g)Cited across public-safe Form 483 observations2x
21 CFR 820.75(a)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 8 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere